Relationship between blood glucose levels and hepatic Fto mRNA expression in mice.
Common variants in the fat mass and obesity associated (FTO) gene are associated with obesity and type 2 diabetes. Fto-deficient mice develop hepatic insulin resistance, leading to the hypothesis that hepatic Fto plays a role in the regulation of glucose metabolism and that hepatic Fto expression is regulated by metabolic states. We found that hepatic Fto mRNA levels were increased by fasting in mice. Intraperitoneal glucose injection reduced hepatic Fto mRNA levels without significant changes in body weight in fasted mice. The inverse correlation between Fto mRNA and glucose remained significant after adjusting for body weight. There were positive correlations between hepatic Fto mRNA expression and gluconeogenic gene expression. These data support the hypothesis that hepatic Fto expression changes in response to metabolic states and glucose reduces hepatic Fto mRNA expression independently of body weight. Hepatic Fto may participate in the feedback regulation of glucose metabolism via gluconeogenesis.
Poritsanos
Nicole J
NJ
Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0J9.
Lew
Pei San
PS
Mizuno
Tooru M
TM
D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; D000818:Animals; D001786:Blood Glucose / Q000235:genetics*; D001835:Body Weight / Q000235:genetics; D005786:Gene Expression Regulation; D005943:Gluconeogenesis / Q000235:genetics*; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011506:Proteins / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism*
D001786:Blood Glucose; D011506:Proteins; D012333:RNA, Messenger; C524916:FTO protein, mouse; D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO